515 related articles for article (PubMed ID: 7836743)
1. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth.
Vigon I; Florindo C; Fichelson S; Guenet JL; Mattei MG; Souyri M; Cosman D; Gisselbrecht S
Oncogene; 1993 Oct; 8(10):2607-15. PubMed ID: 8397366
[TBL] [Abstract][Full Text] [Related]
3. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
4. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
[TBL] [Abstract][Full Text] [Related]
5. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
6. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
Muljo SA; Schlissel MS
Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
[TBL] [Abstract][Full Text] [Related]
7. Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors.
Wendling F; Vigon I; Souyri M; Tambourin P
Leukemia; 1989 Jul; 3(7):475-80. PubMed ID: 2543869
[TBL] [Abstract][Full Text] [Related]
8. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
9. Transforming pathways activated by the v-Abl tyrosine kinase.
Shore SK; Tantravahi RV; Reddy EP
Oncogene; 2002 Dec; 21(56):8568-76. PubMed ID: 12476303
[TBL] [Abstract][Full Text] [Related]
10. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
Blasi E; Radzioch D; Merletti L; Varesio L
Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
[TBL] [Abstract][Full Text] [Related]
11. Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B.
Miller M; Kennewell A; Takayama Y; Bruskin A; Bishop JM; Johnson G; Symonds G
Oncogene; 1990 Aug; 5(8):1125-31. PubMed ID: 2168027
[TBL] [Abstract][Full Text] [Related]
12. Transforming activity and tissue tropism of hybrid retroviral genomes containing portions of the v-abl and v-src oncogenes.
Hevezi P; Alin K; Goff SP
Oncogene; 1993 Sep; 8(9):2413-23. PubMed ID: 8361756
[TBL] [Abstract][Full Text] [Related]
13. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
14. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
15. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
Hines DL
Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
[TBL] [Abstract][Full Text] [Related]
16. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
17. The role of v-mos in transformation, oncogenicity, and metastatic potential of mink lung cells.
Gao CL; Wang LC; Vass WC; Seth A; Chang KS
Oncogene; 1988 Sep; 3(3):267-73. PubMed ID: 2849740
[TBL] [Abstract][Full Text] [Related]
18. Autocrine production of pre-B-cell stimulating activity by a variety of transformed murine pre-B-cell lines.
Lemoine FM; Krystal G; Humphries RK; Eaves CJ
Cancer Res; 1988 Nov; 48(22):6438-43. PubMed ID: 3263188
[TBL] [Abstract][Full Text] [Related]
19. The 'WS motif' common to v-mpl and members of the cytokine receptor superfamily is dispensable for myeloproliferative leukemia virus pathogenicity.
Bénit L; Charon M; Cocault L; Wendling F; Gisselbrecht S
Oncogene; 1993 Mar; 8(3):787-90. PubMed ID: 8382360
[TBL] [Abstract][Full Text] [Related]
20. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
Keller JR; Ruscetti SK; Ruscetti FW
Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
